Insider Trading May 20, 2026 08:46 PM

Director Activity and Corporate Milestones at Momentus Inc. Signal Operational Focus

Insider purchases noted alongside major contract wins and planned mission launches for space infrastructure firm.

By Leila Farooq MNTS

Momentus Inc.'s director, Brian Kabot, recently engaged in multiple stock transactions, including open market purchases of Common Stock and the granting of Restricted Stock Units (RSUs). These insider actions occurred amidst several significant corporate developments for Momentus. The company has provided updated financial guidance, projecting substantial revenue growth driven by defense and NASA contracts, alongside advancing key space missions and restructuring its debt agreements.

Director Activity and Corporate Milestones at Momentus Inc. Signal Operational Focus
MNTS

Key Points

  • Strong Revenue Guidance from Defense and NASA Contracts
  • Progress on Key Missions like Vigoride 8 Launching in Early 2027
  • Capital Infusion through Private Placement and Debt Conversion

Momentus Inc.'s director, Brian Kabot, recently completed multiple transactions involving the company's stock, according to filings with the U.S. Securities and Exchange Commission. These insider purchases provide a current data point on internal confidence within the space infrastructure firm.

Specifically, Mr. Kabot acquired 250 shares of Class A Common Stock through an open market transaction on May 19, 2026. The purchase price for this block of stock was $5.615 per share, totaling a value of $1,403. Furthermore, the director also executed another acquisition of 913 shares of Class A Common Stock on May 18, 2026, at a nominal cost of $0.00 per share.

Following these transactions, Mr. Kabot's direct holdings in Momentus Class A Common Stock increased to 4,458 shares. These recorded insider purchases are occurring as the stock shows signs of recovery momentum. While the stock has experienced a substantial decline of 79% over the past year, it is currently up 28% year-to-date.

Vesting and Compensation Details

In addition to the direct stock acquisitions, Mr. Kabot received 6,039 Restricted Stock Units (RSUs) on May 18, 2026. Each RSU represents a contingent right to receive one share of Momentus Inc.'s Class A Common Stock. The vesting schedule for these units is set to occur fully on the earlier date between May 18, 2027, and the company's annual meeting in 2027. This vesting is conditional upon Mr. Kabot maintaining his service as a member of the Board of Directors through the specified vesting date.


These insider activities are set against a backdrop of several notable corporate achievements for Momentus Inc. The company recently provided updated financial forecasts, projecting significant revenue growth. Momentus anticipates generating $10.0 million in 2026, representing a substantial increase from the $1.1 million projected for 2025. This anticipated revenue acceleration is explicitly tied to milestone-based contracts secured with both NASA and the U.S. Department of Defense.

Operationally, Momentus continues its advancement on key projects. The company successfully completed the Preliminary Design Review (PDR) for its Vigoride 8 mission. This critical mission is scheduled for launch in early 2027 and is set to carry important payloads, including the Spaceworks COSMIC system and NASA’s Juno Rotating Detonation Rocket Engine.

Momentus also undertook significant financial restructuring during this period. The company terminated certain convertible debt agreements after converting outstanding notes into Class A common stock. This action concluded warrants that had previously been issued to Yield Point NY, LLC. Furthermore, the firm bolstered its capital base by closing a private placement of $5 million with a single institutional investor. In this transaction, Momentus sold 1,333,334 shares at a price of $3.75 per share. This sale was conducted at-the-market, adhering to Nasdaq regulations.


Risks

  • Dependence on Future Contract Awards: The projected revenue increase relies heavily on milestone-based contracts with NASA and the U.S. Department of Defense.
  • Execution Risk for Missions: The Vigoride 8 mission's successful launch in early 2027 depends on the completion of its Preliminary Design Review and operational readiness.
  • Market Valuation Fluctuations: Despite insider buying, the stock has shown significant volatility, including a 79% decline over the past year.

More from Insider Trading

CoreWeave CEO Michael Intrator Executes $37.65 Million Share Sale Under Pre-arranged Plan Jun 4, 2026 Datadog CEO Olivier Pomel Executes $6.95 Million Stock Sale Jun 4, 2026 Krispy Kreme Director Bernardo Hees Executes $2.1 Million Share Purchase Amid Financial Headwinds Jun 4, 2026 Genelux Regulatory Chief Executes Minor Stock Sale for Tax Obligations Jun 4, 2026 QuantumScape Executive Timothy Holme Offloads $1.77 Million in Shares Amid Market Volatility Jun 4, 2026